Polymorphisms in methionine synthase, methionine synthase reductase and serine hydroxymethyltransferase, folate and alcohol intake, and colon cancer risk

Journal of Nutrigenetics and Nutrigenomics

Volumn 1, Issue 4, 2008, Pages 196-204

  Steck, Susan E ^a,e   Keku, Temitope ^b,c   Butler, Lesley M ^d   Galanko, Joseph ^b   Massa, Beri ^b   Millikan, Robert C ^b   Sandler, Robert S ^b,c  

^a University of North Carolina   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Alcohol; Case control study; Colon cancer; Folate; Polymorphism

Indexed keywords

ALCOHOL; CARBON; DNA; FOLIC ACID; GLYCINE HYDROXYMETHYLTRANSFERASE; METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE;

ADULT; AFRICAN AMERICAN; AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BLOOD; CALCULATION; CANCER RISK; CARBON METABOLISM; COLON ADENOCARCINOMA; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIET; ENZYME POLYMORPHISM; EUROPEAN AMERICAN; FEMALE; GENE; GENOTYPE; HUMAN; HUMAN TISSUE; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; RACE; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; AGED; ALCOHOL DRINKING; CARCINOMA; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; EATING; FEMALE; FERREDOXIN-NADP REDUCTASE; FOLIC ACID; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLYCINE HYDROXYMETHYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 45749123112     PISSN: 16616499     EISSN: 16616758     Source Type: Journal    
DOI: 10.1159/000136651     Document Type: Article

References (36)

1. Slattery ML, Boucher KM, Caan BJ, Potter JD, Ma KN: Eating patterns and risk of colon cancer. Am J Epidemiol 1998;148:4-16.
2. Little J, Sharp L, Duthie S, Narayanan S: Colon cancer and genetic variation in folate metabolism: the clinical bottom line. J Nutr 2003;133:3758S-3766S.
3. Ulrich CM, Potter JD: Folate supplementation: too much of a good thing? Cancer Epidemiol Biomarkers Prev 2006;15:189-193.
4. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, Snover DC, Church TR, Allen JI, Robertson DJ, Beck GJ, Bond JH, Byers T, Mandel JS, Mott LA, Pearson LH, Barry EL, Rees JR, Marcon N, Saibil F, Ueland PM, Greenberg ER: Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007;297:2351-2359.
5. Rady PL, Szucs S, Grady J, Hudnall SD, Kellner LH, Nitowsky H, Tyring SK, Matalon RK: Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas: a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 2002;107:162-168.
6. Olteanu H, Banerjee R: Human methionine synthase reductase, a soluble P-450 reductase-like dual flavoprotein, is sufficient for NADPH-dependent methionine synthase activation. J Biol Chem 2001;276:35558-35563.
7. Sharp L, Little J: Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol 2004;159:423-443.
8. Keku T, Millikan R, Worley K, Winkel S, Eaton A, Biscocho L, Martin C, Sandler R: 5,10-Methylenetetrahydrofolate reductase codon 677 and 1,298 polymorphisms and colon cancer in African-Americans and whites. Cancer Epidemiol Biomarkers Prev 2002;11:1611-1621.
9. Gerber AM, James SA, Ammerman AS, Keenan NL, Garrett JM, Strogatz DS, Haines PS: Socioeconomic status and electrolyte intake in black adults: the Pitt County Study. Am J Publ Health 1991;81:1608-1612.
10. Lewis CJ, Crane NT, Wilson DB, Yetley EA: Estimated folate intakes: data updated to reflect food fortification, increased bioavailability, and dietary supplement use. Am J Clin Nutr 1999;70:198-207.
11. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R: A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998;64:169-172.
12. Weinberg CR, Sandler DP: Randomized recruitment in case-control studies. Am J Epidemiol 1991;134:421-432.
13. Greenland S, Poole C: Invariants and noninvariants in the concept of interdependent effects. Scand J Work Environ Health 1988;14:125-129.
14. Millikan R: The changing face of epidemiology in the genomics era. Epidemiology 2002;13:472-480.
15. Heil SG, Van der Put NM, Waas ET, den Heijer M, Trijbels FJ, Blom HJ: Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? Mol Genet Metab 2001;73:164-172.
16. Chen J, Kyte C, Valcin M, Chan W, Wetmur JG, Selhub J, Hunter DJ, Ma J: Polymorphisms in the one-carbon metabolic pathway, plasma folate levels and colorectal cancer in a prospective study. Int J Cancer 2004;110:617-620.
17. Chen J, Stampfer MJ, Ma J, Selhub J, Malinow MR, Hennekens CH, Hunter DJ: Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis 2001;154:667-672.
18. Harmon DL, Shields DC, Woodside JV, McMaster D, Yarnell JW, Young IS, Peng K, Shane B, Evans AE, Whitehead AS: Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet Epidemiol 1999;17:298-309.
19. Fredriksen A, Meyer K, Ueland PM, Vollset SE, Grotmol T, Schneede J: Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum Mutat 2007;28:856-865.
20. van der Put NM, van der Molen EF, Kluijtmans LA, Heil SG, Trijbels JM, Eskes TK, Van Oppenraaij-Emmerzaal D, Banerjee R, Blom HJ: Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neuraltube defects and vascular disease. QJM 1997;90:511-517.
21. 12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1999;8:825-829.
22. Jacques PF, Bostom AG, Selhub J, Rich S, Ellison RC, Eckfeldt JH, Gravel RA, Rozen R: Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study. Atherosclerosis 2003;166:49-55.
23. Gaughan DJ, Kluijtmans LA, Barbaux S, McMaster D, Young IS, Yarnell JW, Evans A, Whitehead AS: The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 2001;157:451-456.
24. Geisel J, Zimbelmann I, Schorr H, Knapp JP, Bodis M, Hubner U, Herrmann W: Genetic defects as important factors for moderate hyperhomocysteinemia. Clin Chem Lab Med 2001;39:698-704.
25. O'Leary VB, Parle-McDermott A, Molloy AM, Kirke PN, Johnson Z, Conley M, Scott JM, Mills JL: MTRR and MTHFR polymorphism: link to Down syndrome? Am J Med Genet 2002;107:151-155.
26. Le Marchand L, Wilkens LR, Kolonel LN, Henderson BE: The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2005;14:1198-1203.
27. Matsuo K, Hamajima N, Hirai T, Kato T, Inoue M, Takezaki T, Tajima K: Methionine synthase reductase gene A66G polymorphism is associated with risk of colorectal cancer. Asian Pac J Cancer Prev 2002;3:353-359.
28. Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A: B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control 2002;13:239-248.
29. Goode EL, Potter JD, Bigler J, Ulrich CM: Methionine synthase D919G polymorphism, folate metabolism, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2004;13:157-162.
30. Koushik A, Kraft P, Fuchs CS, Hankinson SE, Willett WC, Giovannucci EL, Hunter DJ: Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer. Cancer Epidemiol Biomarkers Prev 2006;15:2408-2417.
31. Jiang Q, Chen K, Ma X, Li Q, Yu W, Shu G, Yao K: Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer. Cancer Detect Prev 2005;29:146-154.
32. Perry CA, Renna SA, Khitun E, Ortiz M, Moriarty DJ, Caudill MA: Ethnicity and race influence the folate status response to controlled folate intakes in young women. J Nutr 2004;134:1786-1792.
33. Larsson SC, Giovannucci E, Wolk A: A prospective study of dietary folate intake and risk of colorectal cancer: modification by caffeine intake and cigarette smoking. Cancer Epidemiol Biomarkers Prev 2005;14:740-743.
34. Martin S, Ulrich C, Munsell M, Taylor S, Lange G, Bleyer A: Delays in cancer diagnosis in underinsured young adults and older adolescents. Oncologist 2007;12:816-824.
35. Curtin K, Ulrich CM, Samowitz WS, Bigler J, Caan B, Potter JD, Slattery ML: Thymidylate synthase polymorphisms and colon cancer: associations with tumor stage, tumor characteristics and survival. Int J Cancer 2007;120:2226-2232.
36. Reed MC, Nijhout HF, Neuhouser ML, Gregory JF 3rd, Shane B, James SJ, Boynton A, Ulrich CM: A mathematical model gives insights into nutritional and genetic aspects of folate-mediated one-carbon metabolism. J Nutr 2006;136:2653-2661.